Bill > HR2767

This bill, known as the Bolstering Research And Innovation Now Act (BRAIN Act), aims to advance brain tumor research and improve patient care through several key provisions. The bill acknowledges the significant challenges faced by brain tumor patients, noting that over 1 million people in the United States are living with brain tumors and the 5-year survival rate remains low, especially for glioblastoma. The legislation establishes multiple initiatives, including creating a Glioblastoma Therapeutics Network with $50 million in annual funding, launching a Brain Tumor Related Cellular Immunotherapy Team Science Award with $10 million annually, and implementing a national public awareness campaign about cancer clinical trials and biomarker testing. Additionally, the bill supports pilot programs to develop comprehensive monitoring and care approaches for brain tumor survivors, mandates the creation of a searchable database of brain tumor biospecimens, and requires the FDA to issue guidance to ensure brain tumor patients have better access to clinical trials. The overall purpose is to strengthen brain tumor research, improve treatment options, increase public awareness, and ultimately enhance the quality of life for patients and their families by addressing the critical gaps in brain tumor research and care.

Business and Industry

https://www.congress.gov/bill/119th-congress/house-bill/2767/all-info